National Foundation for Infectious Diseases

3 Things To Know on World Pneumonia Day

Retrieved on: 
Thursday, November 9, 2023
National Foundation for Infectious Diseases, Streptococcus, Fungal infection, Respiratory failure, Attenuated vaccine, Vaccine, American Lung Association, MD, NFID, HIV, Diabetes, Sickle cell disease, Kidney, Fever, Cough, Chest pain, Vaccination, Disease, Risk, Immune system, COVID-19, Asthma, Chills, Infection, Sepsis, Diagnosis, Death, Pneumonia

In support of World Pneumonia Day on November 12, NFID and the American Lung Association are working to raise awareness about pneumococcal disease and encourage those who are at risk to talk with a healthcare professional about pneumococcal vaccination.

Key Points: 
  • In support of World Pneumonia Day on November 12, NFID and the American Lung Association are working to raise awareness about pneumococcal disease and encourage those who are at risk to talk with a healthcare professional about pneumococcal vaccination.
  • Here are 3 things to know on World Pneumonia Day:
    Anyone can get pneumonia, but some people are at higher risk.
  • "Even healthy adults over 65 years are at increased risk for pneumococcal pneumonia, because the body's immune system naturally weakens with age.
  • "Fortunately, pneumococcal pneumonia vaccines are available to help prevent the disease."

US Health Officials Urge Vaccination Against Flu, COVID-19, and RSV This Fall and Winter

Retrieved on: 
Thursday, September 28, 2023
Vaccine, United Nations Foundation, Infection, National Foundation for Infectious Diseases, Tulane University School of Medicine, Pregnancy, Streptococcus, Hopkins, Diabetes, Education, Vaccination, Hospital, COVID-19, Woman, Medicine, Pharmacy, Doctor of Philosophy, MS, CDC, Death, CPNP, RSV, Mask, Risk, Patient, Korea Disease Control and Prevention Agency, Brace, Immune system, Schaffner, RN, Health, Cardiology, MPH, White, News, Kidney disease, NFID, Pharmaceutical industry, MD

BETHESDA, Md., Sept. 28, 2023 /PRNewswire/ -- As the US braces for the upcoming fall and winter virus season, new survey data released today by the National Foundation for Infectious Diseases (NFID) show that despite the potential severity, only 22% of US adults are worried about themselves or someone in their family getting infected with influenza (flu), with similar low levels of concern about COVID-19 (23%) and respiratory syncytial virus (RSV) (19%) infection. The data also show that although nearly two-thirds of US adults (65%) agree that vaccination is the best preventive measure against flu-related hospitalizations and deaths, 43% of US adults do not plan to or are unsure if they will get vaccinated against flu. Although updated COVID-19 vaccines are recommended, only 40% plan to get vaccinated against COVID-19, and among adults age 60 years and older, only 40% plan to get vaccinated against RSV.

Key Points: 
  • We must use all available tools to protect those most at risk, including infants and young children, pregnant people, older adults, and those with chronic health conditions."
  • "The NFID data—which show complacency around vaccination against flu, COVID-19, RSV, and pneumococcal disease—are concerning," said NFID President Patricia (Patsy) A. Stinchfield, RN, MS, CPNP.
  • "Even in cases when vaccination does not prevent infection entirely, getting vaccinated can help protect against serious complications, including hospitalization and death."
  • "Flu season is a great time to ask about pneumococcal vaccination because pneumococcal disease can be a serious complication of flu."

NFID Celebrates 50th Anniversary with Gala Honoring Public Health Heroes

Retrieved on: 
Wednesday, August 23, 2023
Vaccine, National Foundation for Infectious Diseases, CAE, PE, Vaccine-preventable diseases, Doctor of Pharmacy, Education, Medical college, COVID-19, Infection, Hepatitis B, Human, Research, History, Doctor of Philosophy, Respiratory syncytial virus, Bangladesh Technical Education Board, MS, CDC, Organization, CPNP, Pharmacist, RSV, National Immunization Technical Advisory Group, Nursing, Korea Disease Control and Prevention Agency, Cystic fibrosis, Schaffner, Duma, RN, MPH, Immunization, Conference, News, NFID, Pharmaceutical industry, MD

BETHESDA, Md., Aug. 23, 2023 /PRNewswire/ -- Today marks the 50th anniversary of the establishment of the National Foundation for Infectious Diseases (NFID) which will be commemorated with an elegant 50th Anniversary Gala in Washington, DC on September 14, 2023.

Key Points: 
  • BETHESDA, Md., Aug. 23, 2023 /PRNewswire/ -- Today marks the 50th anniversary of the establishment of the National Foundation for Infectious Diseases (NFID) which will be commemorated with an elegant 50th Anniversary Gala in Washington, DC on September 14, 2023.
  • Celebrating 50 years of education, prevention, and impact, the gala will recognize the work of NFID and the inspirational public health heroes who have helped protect the lives of millions.
  • NFID supporters and public health luminaries will gather in Washington, DC to celebrate the remarkable history and notable accomplishments at the NFID 50th Anniversary Gala on September 14, 2023.
  • An NFID 50th Anniversary Commemorative Book that looks back at the history of NFID and celebrates the trailblazing efforts of NFID leaders and public health heroes over the past 5 decades is also available for purchase online.

NFID Names Robert H. Hopkins, Jr., MD, as Medical Director

Retrieved on: 
Thursday, July 20, 2023
Vaccine, National Foundation for Infectious Diseases, Immunization, CAE, University, Hopkins, Education, Internal medicine, Human services, Public, Pediatrics, University of Arkansas for Medical Sciences, Advisory Committee, Medicine, UAMS, Human, Infection, Advisory Committee on Immunization Practices, Korea Disease Control and Prevention Agency, Growth, American College, NFID, Pharmaceutical industry, Management, Nursing, MD

BETHESDA, Md., July 20, 2023 /PRNewswire/ -- The National Foundation for Infectious Diseases (NFID) has announced the appointment of Robert H. Hopkins, Jr., MD, as its new medical director.

Key Points: 
  • BETHESDA, Md., July 20, 2023 /PRNewswire/ -- The National Foundation for Infectious Diseases (NFID) has announced the appointment of Robert H. Hopkins, Jr., MD, as its new medical director.
  • Hopkins succeeds William Schaffner, MD, who served NFID for many years and will continue to serve as an NFID spokesperson, lending his expertise to NFID initiatives.
  • As medical director, Hopkins will focus on the growth of NFID programs, including efforts to build vaccine confidence, address health equity issues, increase awareness of disease prevention and treatment, and strengthen NFID partner collaborations.
  • In his role as NFID medical director, Hopkins will also serve as an ex-officio member of the NFID Board of Directors and all Board-level committees.

CGTN: China monitors coronavirus mutations to adjust COVID-19 response

Retrieved on: 
Sunday, January 1, 2023
WHO, United Nations Foundation, CNBC, Routing protocol, Ibuprofen, Tablet, University, Interview, COVID-19, National Foundation for Infectious Diseases, Control, GISAID, National Health Commission, Risk, NHC, Division, Infection, Coronavirus, Public health, Ministry of Industry and Information Technology, Ministry, Diagnosis, Vanderbilt University Medical Center, Viral disease, Database, Wuhan Center, University of Washington Department of Global Health, Vaccine, CNN, Relaxation, Information technology, Animal, Pharmaceutical industry, Omicron, Nashville City Cemetery, Chinese Center for Disease Control and Prevention

Xu said that the country has formulated a work plan to monitor the novel coronavirus variant strains since it optimized COVID-19 prevention and control measures.

Key Points: 
  • Xu said that the country has formulated a work plan to monitor the novel coronavirus variant strains since it optimized COVID-19 prevention and control measures.
  • The National Health Commission (NHC) and China CDC held a video meeting with the WHO, and exchanged views on the current COVID-19 situation, treatment and vaccinations.
  • Technical exchanges would be continued to help end the epidemic worldwide as soon as possible, according to the NHC.
  • China has made efforts to enhance the medical supplies needed, including therapeutic medicines, testing reagents, vaccines, medical masks and protective suits.

CGTN: China monitors coronavirus mutations to adjust COVID-19 response

Retrieved on: 
Sunday, January 1, 2023
WHO, United Nations Foundation, CNBC, Routing protocol, Ibuprofen, Tablet, University, Interview, COVID-19, National Foundation for Infectious Diseases, Control, GISAID, National Health Commission, Risk, NHC, Division, Infection, Coronavirus, Public health, Ministry of Industry and Information Technology, Ministry, Diagnosis, Vanderbilt University Medical Center, Viral disease, Database, Wuhan Center, University of Washington Department of Global Health, Vaccine, CNN, Relaxation, Information technology, Animal, Pharmaceutical industry, Omicron, Nashville City Cemetery, Chinese Center for Disease Control and Prevention

Xu said that the country has formulated a work plan to monitor the novel coronavirus variant strains since it optimized COVID-19 prevention and control measures.

Key Points: 
  • Xu said that the country has formulated a work plan to monitor the novel coronavirus variant strains since it optimized COVID-19 prevention and control measures.
  • The National Health Commission (NHC) and China CDC held a video meeting with the WHO, and exchanged views on the current COVID-19 situation, treatment and vaccinations.
  • Technical exchanges would be continued to help end the epidemic worldwide as soon as possible, according to the NHC.
  • China has made efforts to enhance the medical supplies needed, including therapeutic medicines, testing reagents, vaccines, medical masks and protective suits.

COALITION TO STOP FLU APPLAUDS INTRODUCTION OF LEGISLATION TO BETTER PROTECT AMERICA FROM SEASONAL AND PANDEMIC INFLUENZA

Retrieved on: 
Thursday, December 8, 2022
Therapy, House, Trust, City, State, Vaccine, Senate, Association of Public Health Laboratories, Trust for America's Health, Biotechnology, Infectious Diseases Society of America, Infection, BD, Protect America Act of 2007, American Heart Association, Association of State and Territorial Health Officials, Alvogen, Korea Disease Control and Prevention Agency, Hospital, National Association, Public health, Society, Partnership, Policy, Administration, Public, Death, American Society for Microbiology, National Foundation for Infectious Diseases, GSK, Health, Congress, Microbiology, United Nations Foundation, Influenza, Legislation, CDC, Coalition, Genentech

WASHINGTON, Dec. 8, 2022 /PRNewswire/ -- The Coalition to Stop Flu, a multi-sector advocacy coalition dedicated to ending deaths from seasonal and pandemic influenza, applauds the Protecting America from Seasonal and Pandemic Influenza Act (The Influenza Act), introduced today in the House of Representatives by Congressman Rick Larsen (D-WA-02), along with Representatives Deborah Ross (D-NC-02), Ami Bera (D-CA-07), Salud Carbajal (D-CA-24), Nanette Diaz Barragán (D-CA-44) and Eleanor Holmes Norton (D-DC-At-Large). The legislation comes at a critical moment, as influenza rates are at their highest level in more than a decade and many hospitals have been pushed to the brink. The bill is the first comprehensive effort to enact proactive federal policy changes to stop flu deaths in our lifetime.

Key Points: 
  • The bill is the first comprehensive effort to enact proactive federal policy changes to stop flu deaths in our lifetime.
  • "And pandemic influenza remains an extraordinary threat to our nation's health and prosperity.More can, and must, be done.
  • The Influenza Actprovides commonsense solutions to improve our ability to prepare for and respond to seasonal and pandemic flu."
  • The Coalition to Stop Flu is a multi-sector advocacy coalition dedicated to ending deaths from seasonal and pandemic influenza.

Pervistop®, the once-daily supplement specifically designed to manage persistent HPV, is now available for exclusive distribution rights worldwide.

Retrieved on: 
Tuesday, November 1, 2022
Marketing, EGCG, United Nations Foundation, Gynaecology, Partnership, General manager, Cancer, National Foundation for Infectious Diseases, Research, Disease, Medical device, Human papillomavirus infection, HPV, Shijiazhuang Pharma Group, Infection, Wart, Woman, Cervical cancer, Patient, Man, Grammatical mood, Functional, Inositol, Fine chemical

FRANKFURT, Germany, Nov. 1, 2022 /PRNewswire/ -- Lo.Li. Pharma International announces the pre-launch of a new, highly anticipated product at CPHI 2022, fulfilling a latent unmet clinical need for patients with the Human Papilloma Virus (HPV). As the largest pharma industry event worldwide, CPHI Frankfurt will allow thousands of participants to have a first look at this innovative product, whose exclusive formula helps to counteract the signs, symptoms, and persistence of HPV.

Key Points: 
  • Pharma International to unveil an innovative new product at CPHI Frankfurt, which has already gained the interest of numerous distribution partners.
  • Pervistop promises to be an extremely effective tool in the management of an exceedingly unpredictable disease.
  • HPV is the most common sexually transmitted infection worldwide, and it is known to cause certain cancers and genital warts.
  • Pharma International is committed to supporting our Partners through equitable, exclusive distribution agreements, while sharing the scientific know-how and marketing strategies, which are needed to be successful.

Pervistop®, the once-daily supplement specifically designed to manage persistent HPV, is now available for exclusive distribution rights worldwide.

Retrieved on: 
Tuesday, November 1, 2022
Marketing, EGCG, United Nations Foundation, Gynaecology, Partnership, General manager, Cancer, National Foundation for Infectious Diseases, Research, Disease, Medical device, Human papillomavirus infection, HPV, Shijiazhuang Pharma Group, Infection, Wart, Woman, Cervical cancer, Patient, Man, Grammatical mood, Functional, Inositol, Fine chemical

FRANKFURT, Germany, Nov. 1, 2022 /PRNewswire/ -- Lo.Li. Pharma International announces the pre-launch of a new, highly anticipated product at CPHI 2022, fulfilling a latent unmet clinical need for patients with the Human Papilloma Virus (HPV). As the largest pharma industry event worldwide, CPHI Frankfurt will allow thousands of participants to have a first look at this innovative product, whose exclusive formula helps to counteract the signs, symptoms, and persistence of HPV.

Key Points: 
  • Pharma International to unveil an innovative new product at CPHI Frankfurt, which has already gained the interest of numerous distribution partners.
  • Pervistop promises to be an extremely effective tool in the management of an exceedingly unpredictable disease.
  • HPV is the most common sexually transmitted infection worldwide, and it is known to cause certain cancers and genital warts.
  • Pharma International is committed to supporting our Partners through equitable, exclusive distribution agreements, while sharing the scientific know-how and marketing strategies, which are needed to be successful.

Walgreens Flu Index Shows Flu Activity Trending 10 Times Higher Year Over Year

Retrieved on: 
Monday, October 24, 2022
Women, Infectious Diseases, Men, Family, Other Health, Health, Consumer, Pharmaceutical, General Health, Walgreens Boots Alliance, Infection, Streptococcus, COVID, National, Patient, Hospital, National Foundation for Infectious Diseases, Index, Nasdaq, Technology, Centers for Disease Control and Prevention, Health, Incidence, Season, Pharmacist, Map, Pharmacy, WBA, Meat, Vaccine, Walgreens

Through the time lapse feature of the Walgreens Flu Index, users can see how current flu activity compares to activity from last season.

Key Points: 
  • Through the time lapse feature of the Walgreens Flu Index, users can see how current flu activity compares to activity from last season.
  • On a weekly basis, Walgreens tracks the incremental change of antiviral medications used to treat influenza across thousands of Walgreens and Duane Reade locations nationwide to create the Walgreens Flu Index.
  • The Walgreens Flu Index is updated weekly each Tuesday and is available through an online, interactive map, linked here .
  • For example, red regions on the Walgreens Flu Index map indicates a much higher than a normal flu season, while green regions indicate a much lower than normal flu season.